Advertisement
Canada markets closed
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7320
    +0.0019 (+0.26%)
     
  • CRUDE OIL

    83.34
    +1.44 (+1.76%)
     
  • Bitcoin CAD

    90,532.69
    -454.30 (-0.50%)
     
  • CMC Crypto 200

    1,430.64
    +15.88 (+1.12%)
     
  • GOLD FUTURES

    2,336.00
    -10.40 (-0.44%)
     
  • RUSSELL 2000

    2,004.21
    +36.74 (+1.87%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ

    15,696.64
    +245.33 (+1.59%)
     
  • VOLATILITY

    15.83
    -1.11 (-6.55%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6837
    -0.0013 (-0.19%)
     

Insys Therapeutics founder, former executives found guilty in criminal fentanyl bribery case

A Boston jury convicted Insys Therapeutics founder John Kapoor and other former executives of racketeering and other crimes. Federal prosecutors say the fentanyl bribery case helped fuel the U.S. opioid epidemic. Prosecutors accused Kapoor and four former executives of bribing doctors to unnecessarily prescribe their painkiller, Subsys.